- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
112 |
KATHERINE BARAN, ILIA VOSKOBOINIK, NIGEL J. WATERHOUSE, VIVIEN R. SUTTON, AND JOSEPH A. TRAPANI |
contribute to tumor immune surveillance by lysing tumor cells (Kishi et al., 2002; Sekiya et al., 2002; Stenger et al., 1998; Wang et al., 2000). The mechanism of granulysin action is unclear, but it is believed to mediate its effect by association with negatively charged lipids after granule exocytosis (Kaspar et al., 2001; Krensky, 2000). The crystal structure of granulysin shows a multihelical structure, and the association of granulysin with the plasma membrane predicts a scissoring motion, tunneling granulysin into the plasma membrane and resulting in membrane tearing (Anderson et al., 2003). Granulysin-induced membrane damage leads directly to the activation of apoptotic machinery within the cell through intracellular calcium flux and subsequent mitochondrial damage (Kaspar et al., 2001; Okada et al., 2003). Damaged mitochondria release cytochrome c and apoptosis-inducing factor, resulting in the activation of caspases and endonucleases (Kaspar et al., 2001; Pardo et al., 2001). It has been proposed that although granulysin can function independently on extracellular pathogens, it requires perforin to kill cells that harbor an intracellular pathogen (Dieli et al., 2001; Walch et al., 2007). In addition to its lytic role, granulysin can also function by recruiting immune cells to a site of inflammation (Deng et al., 2005).
3.3. Granzymes
Apart from perforin, granzymes represent the most abundant constituents of CL granules, and their role in cytotoxicity was proposed after certain protease inhibitors were shown to abrogate cytotoxicity in vitro (Chang and Eisen, 1980; Masson and Tschopp, 1987; Redelman and Hudig, 1980). Granzyme involvement in the apoptotic pathway of dying cells was subsequently confirmed when proteins corresponding to grA and grB were isolated from rat NK cells and displayed DNAfragmenting ability (Shi et al., 1992).
3.3.1. GrB-mediated apoptosis
In the early 1990s, caspases were emerging as proteases that orchestrated cell death by apoptosis. Caspases are present in the cytoplasm of cells; however, they must be activated by cleavage after specific aspartic acid residues. Because grB has aspase activity, it was postulated that grB may cleave and activate procaspases. Indeed, using cytosolic extracts, several groups demonstrated that grB efficiently cleaved caspase-3, -7, and -8 (Fernandes-Alnemri et al., 1996; Martin et al., 1996). Caspases also cleave their substrates after specific aspartic acid residues, permitting them to autoactivate.
GrB-mediated processing of caspase-3 was partly inhibited by the addition of the caspase inhibitor zVADfmk, suggesting that this event occurred by a two-step process in which grB was only required for the first step (Darmon et al., 1995; Sutton et al., 2000). Subsequently, it was shown that although grB can initiate caspase activation in intact cells, even high concentrations of grB could not fully process pro-caspases on its own (Barry et al., 2000; Sedelies et al., 2008; Sutton et al., 2000; Sutton et al., 2003; Waterhouse et al., 2006a).
Importantly, caspase inhibitors could block the nuclear damage associated with apoptosis, but they could not block grB-induced cell death (Sarin et al., 1998; Trapani et al., 1998a). In contrast, over-expression of Bcl-2 in the target cell did block cell death mediated, in particular, by human grB, leading to clonogenic survival (Davis et al., 2000; Heibein et al., 2000; Sutton et al., 2000; Sutton et al., 1997). The proapoptotic BH3-only Bcl-2 family member Bid is an excellent substrate for human grB, and the cleaved product, truncated Bid (tBid), translocates to the mitochondrial outer membrane, where it can interact with Bcl-2 to release its hold on the proapoptotic Bax and Bak proteins (Alimonti et al., 2001; Heibein et al., 2000; Sutton et al., 2000). Bid’s involvement in cell death mediated by human grB is crucial, as Bid-deficient cells were resistant to grB-mediated apoptosis and continued to proliferate in long-term survival assays (Waterhouse et al., 2005). After Bid cleavage, grB-mediated mitochondrial outer membrane permeabilization results in the release of proapoptotic proteins such as cytochrome c, Smac/DIABLO, and Htra2/omi (Alimonti et al., 2001; Barry et al., 2000; Sutton et al., 2000; Sutton et al., 2003). GrB has also been shown to cleave antiapoptotic Bcl2 family member Mcl-1, resulting in the release of proapoptotic Bim and subsequent cell cytotoxicity (Han et al., 2005) by a similar mechanism to that of Bid.
GrB has also been proposed to directly cleave various additional substrates that influence cell death, including inhibitor of caspase-activated DNAse (ICAD), and ICADdeficient murine embryonic fibroblasts were markedly resistant to grB-mediated DNA fragmentation (Cullen et al., 2007; Sharif-Askari et al., 2001; Thomas et al., 2000). Moreover, other nuclear substrates, such as poly(ADP-ribose) polymerase (PARP), DNA-dependent protein kinase, NuMA, and lamin B, were also directly cleaved by grB and may contribute to cell death (Andrade et al., 1998; Froelich et al., 1996a; Zhang et al., 2001a). Recent studies using human grB and primary NK cells have shown that over-expression of Bcl-2 and blocking caspase activity maintains the clonogenic survival
CYTOTOXIC GRANULES HOUSE POTENT PROAPOPTOTIC TOXINS CRITICAL FOR ANTIVIRAL RESPONSES |
113 |
of target cells, suggesting that if human grB does cleave these other substrates, they do overtly result in cell death (Sedelies et al., 2008).
Many studies previously detailed strongly suggested that mitochondrial disruption precedes caspase activation during grB-mediated cell death; however, studies in mouse models suggested that mitochondria were not critical for grB-induced death (Metkar et al., 2003). Recently, the reason for these discrepancies has become clear: Although both require Asp at the P1 substrate position, human and mouse grB show differences in their substrate specificities, with human grB preferentially cleaving Bid and mouse grB being relatively more efficient at cleaving pro-caspase 3 directly (CasciolaRosen et al., 2007; Cullen et al., 2007; Kaiserman et al., 2006). Although these distinct differences exist at a biochemical level, similar to the human system (Sedelies et al., 2008), mouse grB delivered by CTL efficiently triggered both cytochrome c release and mitochondriaindependent activation of caspases (Pardo et al., 2008). In contrast to the human system, blocking mitochondrial damage and caspase activity did not protect target cells from death induced by mouse CTsL, suggesting that mouse grB may also target additional deathinducing substrates. The recent finding that the grB gene is highly polymorphic in wild mice may also provide a rationale for the different substrate specificities of human and mouse grB (Thia and Trapani, 2007). It has been proposed that viral pathogens of different species may have applied different selective pressures so that the grB gene in mice may have evolved to counter potential viral escape (Thia and Trapani, 2007). Thus the cell death pathways mediated by grB of different species may be significantly different.
3.3.2. GrA-mediated cell death
Granzyme A (grA)–induced cell death is entirely dependent on the contribution of the mitochondria and not on caspases (Beresford et al., 1999; Martinvalet et al., 2005). GrA induces loss of mitochondrial inner membrane potential and increased production of reactive oxygen species (ROS); however, the proapoptotic mitochondrial factors that are released in response to grB (cytochrome c, Smac/DIABLO, Htra2/omi) remain sequestered in the mitochondria (Martinvalet et al., 2005). ROS production is believed to then mediate the translocation of the SET complex to the nucleus, consistent with its involvement in DNA repair in response to oxidative stress (Chowdhury et al., 2006; Fan et al., 2003b). GrA has specificity for the DNA repair proteins of the SET complex, namely HMG2, Ape1, and SET (Beresford et al., 2001; Fan
et al., 2002; Fan et al., 2003b). GrA breaks the association between SET and HH23-H1, allowing HH23-H1 to act as the grA-activated DNase and nick DNA (Fan et al., 2003a). After its release into the cytosol, grA translocates to the nucleus, where it can target proteins involved in maintaining chromatin and nuclear envelop stability, such as histones, laminins, PARP, and Ku70 (Jans et al., 1998; Zhang et al., 2001a; Zhang et al., 2001b). Until recently, it was unclear how grA stimulated ROS production; however, a recent study proposes that grA enters the mitochondria and cleaves, NDUFS3, a subunit of complex I in the electron transport chain (Martinvalet et al., 2008). This disrupts complex I driven respiration, resulting in increased ROS production. This, however, leaves at least two unanswered questions: (1) How does grA enter the mitochondria? (2) How does the ROS produced result in caspase-independent cell death, especially because blocking complex I with rotenone triggers cell death by a caspase-dependent mechanism (Li et al., 2003)? It possible that ROS contributes to grA-induced death, but this is unlikely to be the whole story, and other substrates for grA remain to be uncovered. The pathways currently proposed for grAand grB-induced cell death are shown in Figure 10-2.
3.3.3. Orphan granzyme-mediated cell death
Granzymes C, D, E, F, G, H, K, M, and N have been termed the orphan granzymes because their specific substrates and functions are yet to be discovered (Grossman et al., 2003). The development of the grB gene-disrupted mice resulted in the accidental knock-down of additional genes within the locus, in particular grC and grF (Pham et al., 1996). These mice have been interpreted to represent a compound knockout for several granzymes; however, grC mRNA levels were only 10-fold less than wild-type mice, when CTLs from grA–/–grB–/– mice were activated in mixed lymphocyte reactions. It is not clear whether this reduction was sufficient to abrogate the function of grC; however, when grB alone was “knocked down,” the cytotoxic defects were not as pronounced, suggesting a role for these orphan granzymes in cytotoxicity (Revell et al., 2005). Individual knockout models have not yet been generated for all the granzymes but will be needed to understand the individual functions of the orphan granzymes.
Purified granzymes C, K, H, and M have all been shown to be capable of inducing cell death when delivered by perforin in vitro, but their cellular substrates are unclear (Fellows et al., 2007; Johnson et al., 2003; Kelly et al., 2004; MacDonald et al., 1999). Both granzyme C and K can induce death independently of caspases,
114 |
KATHERINE BARAN, ILIA VOSKOBOINIK, NIGEL J. WATERHOUSE, VIVIEN R. SUTTON, AND JOSEPH A. TRAPANI |
Figure 10-2. GrA and grB show di erent substrate specificities within the target cell. GrA induces the release of ROS from the mitochondrial inner membrane, which mediates the translocation of the SET complex from the ER to the nucleus. A DNAse component of SET mediates DNA damage and subsequent cell death. Human grB induces apoptosis by cleaving Bid to tBid, where it releases Bcl-2’s hold on Bax/Bak. Bax/Bak polymerize and induce mitochondrial outer membrane permeabilization, releasing mitochondrial proteins, cytochrome c, and Smac/DIABLO. Cytochrome c interacts with APAF-1 to form an apoptosome, which functions by concentrating and activating caspase-9. Caspase-9 cleaves and activates e ector caspase-3, which mediates DNA damage. Smac/DIABLO function by deregulating inhibitors of apoptosis (IAP). By contrast, mouse grB preferentially induces apoptosis by directly cleaving pro-caspase-3 to active caspase-3. See Color Plate 11.
possibly through ROS production (Johnson et al., 2003; MacDonald et al., 1999; Zhao et al., 2007a; Zhao et al., 2007b). Granzyme C induces single-stranded DNA nicks, but the DNAse responsible is unknown (Johnson et al., 2003). Granzyme H and K can cleave Bid; however, the kinetics are slow. Granzyme M–induced death is rapid and occurs independently of caspases and mitochondrial perturbation by direct cleavage of nuclear substrates ICAD and PARP (Kelly et al., 2004; Lu et al., 2006). The putative cell death mechanisms activated by the various granzymes are described briefly (Table 10-4).
4. A ROLE FOR GRANULE PROTEINS IN VIRAL RESPONSE,
IMMUNE SURVEILLANCE, AND IMMUNE HOMEOSTASIS
It is imperative for the immune system to mount an attack on virus-infected or transformed cells, a process that is extremely dependent on cytotoxic granule proteins. It is also extremely important that the immune system diminishes lymphocyte populations afterwards to maintain cellular homeostasis. Although this latter process is thought to be primarily dependent on receptormediated death, cytotoxic granule proteins can also play a role, as indicated from studies with gene-disrupted mice and humans.
CYTOTOXIC GRANULES HOUSE POTENT PROAPOPTOTIC TOXINS CRITICAL FOR ANTIVIRAL RESPONSES |
115 |
Table 10-4. Granzymes and their putative role in cell death pathways
Granzyme Function
AMitochondrial depolarization and ROS formation; cleavage of SET complex of the ER and resulting in single-strand DNA nicks (see text)
BCaspase-dependent and -independent apoptosis (see text)
CCaspase-independent mitochondrial inner membrane depolarization, with subsequent ROS formation, resulting in single-strand DNA nicks (Johnson et al., 2003)
DNone yet proposed
ENone yet proposed
FNone yet proposed
GNone yet proposed
HCaspase-independent mitochondrial inner membrane depolarization, with subsequent ROS formation, resulting in single-strand DNA nicks (also cleaves adenoviral proteins important for viral DNA replication) (Andrade et al., 2007; Fellows et al., 2007).
JNone yet proposed
KCaspase-dependent Bid cleavage; caspase-independent mitochondrial inner membrane depolarization, with subsequent ROS formation, resulting in single-strand DNA nicks (MacDonald et al., 1999; Zhao et al., 2007a; Zhao et al., 2007b)
LNone yet proposed
MCaspase-independent direct ICAD and PARP cleavage (Kelly et al., 2004; Lu et al., 2006; Pao et al., 2005)
NNone yet proposed
CL from perforin-deficient mice showed a marked decrease in their cytolytic function against lymphocytic choriomeningitis (LCMV) infected cells in vitro (Kagi et al., 1994). In addition to controlling the spread of viruses, there is evidence that perforin has a role in immune surveillance, that is, the elimination of transformed cells before their presentation as a clinical malignancy (Smyth et al., 2000; van den Broek et al., 1996). Considerable evidence suggests an additional role for perforin in immune regulation. Perforin-deficient mice show increased clonal expansion and persistence of virus-specific T cells and an inability to downregulate T-cell responses during chronic LCMV infection (Kagi et al., 1999; Matloubian et al., 1999). In LCMV infection, high levels of activated CTLs cannot be cleared, and the activated lymphocytes and macrophages infiltrate various organs, resulting in massive release of inflammatory cytokines, tissue necrosis, and organ failure, features very similar to those seen with human patients suffering from FHL (Arico, 1991). Among other causes, FHL can result from the absence of perforin expression within the granules and subsequent defective CL function (Stepp et al., 1999; Voskoboinik et al., 2006). Incomplete loss of perforin function has also been linked to hematological cancer, although these studies involved small numbers of patients (Clementi et al., 2005; Mehta et al., 2006; Voskoboinik et al., 2007). Perforin may also be a
critical mediator of tissue damage, controlling autoimmune beta-cell destruction that results in type 1 diabetes in nonobese diabetic mice (Kagi et al., 1997).
GrAand grB-deficient mice both show some increased mortality when infected with ectromelia virus. However, in contrast with CTLs from grA mice whose apoptotic response is unaltered, delayed nuclear apoptotic changes are evident in target cells when treated with grB-deficient CTL (Ebnet et al., 1995; Heusel et al., 1994). In contrast to mice deficient in a single granzyme, mice that are deficient for both grA and grB are remarkably (about a million-fold) more susceptible to fatal ectromelia infection (Mullbacher et al., 1999). Furthermore, allogeneic CTLs isolated from these mice induce an alternative form of cell death that largely resembles apoptosis morphologically but features the delayed expression of markers of phagocytosis (Waterhouse et al., 2006b).
5. CONCLUSIONS
Many unanswered questions still remain regarding the function of CL secretory granule proteins. As a crucial molecule in the granule exocytosis pathway, it is unclear how perforin functions at the molecular level. Perforin is critical for mediating granzyme entry into the target cell; however, the mechanism for this synergy still remains
